Bartlett & Co. LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 559.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 3,559 shares of the medical equipment provider’s stock after purchasing an additional 3,019 shares during the period. Bartlett & Co. LLC’s holdings in Intuitive Surgical were worth $1,922,000 at the end of the most recent reporting period.
Other large investors also recently added to or reduced their stakes in the company. Manchester Financial Inc. purchased a new stake in Intuitive Surgical during the 2nd quarter worth approximately $25,000. Golden State Wealth Management LLC purchased a new stake in Intuitive Surgical during the 3rd quarter worth approximately $35,000. Nelson Van Denburg & Campbell Wealth Management Group LLC grew its position in Intuitive Surgical by 733.3% during the 2nd quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 75 shares of the medical equipment provider’s stock worth $39,000 after purchasing an additional 66 shares during the last quarter. North Star Investment Management Corp. purchased a new stake in Intuitive Surgical during the 3rd quarter worth approximately $49,000. Finally, FNY Investment Advisers LLC purchased a new stake in Intuitive Surgical during the 2nd quarter worth approximately $47,000. 85.73% of the stock is currently owned by institutional investors.
In related news, EVP Curet Myriam sold 3,000 shares of the stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $553.54, for a total transaction of $1,660,620.00. Following the sale, the executive vice president now directly owns 3,851 shares of the company’s stock, valued at $2,131,682.54. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Marshall Mohr sold 7,500 shares of the stock in a transaction on Monday, October 28th. The stock was sold at an average price of $548.43, for a total transaction of $4,113,225.00. Following the sale, the chief financial officer now directly owns 20,135 shares in the company, valued at $11,042,638.05. The disclosure for this sale can be found here. Insiders have sold 13,037 shares of company stock worth $7,105,808 over the last three months. 1.70% of the stock is currently owned by insiders.
Several analysts have recently commented on the stock. Canaccord Genuity reaffirmed a “buy” rating and issued a $610.00 price objective (up from $575.00) on shares of Intuitive Surgical in a report on Friday, July 19th. Wells Fargo & Co set a $620.00 price objective on shares of Intuitive Surgical and gave the company a “buy” rating in a report on Friday, October 18th. BidaskClub downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Wednesday, September 11th. Redburn Partners assumed coverage on shares of Intuitive Surgical in a report on Friday, September 13th. They issued a “buy” rating on the stock. Finally, Royal Bank of Canada set a $570.00 price objective on shares of Intuitive Surgical and gave the company a “hold” rating in a report on Friday, October 18th. Three research analysts have rated the stock with a sell rating, four have issued a hold rating and ten have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $583.00.
Shares of NASDAQ ISRG opened at $548.95 on Friday. The company’s fifty day moving average price is $539.58 and its 200 day moving average price is $516.02. Intuitive Surgical, Inc. has a 1 year low of $430.24 and a 1 year high of $589.32. The company has a market capitalization of $65.11 billion, a PE ratio of 57.85, a price-to-earnings-growth ratio of 4.07 and a beta of 1.12.
Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $3.43 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.99 by $0.44. Intuitive Surgical had a net margin of 30.94% and a return on equity of 18.26%. The firm had revenue of $1.13 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same period in the prior year, the firm posted $2.83 earnings per share. The firm’s quarterly revenue was up 22.5% compared to the same quarter last year. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 10.9 earnings per share for the current fiscal year.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Read More: How to trade on quiet period expirations
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.